IL100906A - Pharmaceutical compositions comprising carminic acid and optionally one or more quinones - Google Patents

Pharmaceutical compositions comprising carminic acid and optionally one or more quinones

Info

Publication number
IL100906A
IL100906A IL10090692A IL10090692A IL100906A IL 100906 A IL100906 A IL 100906A IL 10090692 A IL10090692 A IL 10090692A IL 10090692 A IL10090692 A IL 10090692A IL 100906 A IL100906 A IL 100906A
Authority
IL
Israel
Prior art keywords
composition
quinone
acid
moles
concentration
Prior art date
Application number
IL10090692A
Other languages
English (en)
Other versions
IL100906A0 (en
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of IL100906A0 publication Critical patent/IL100906A0/xx
Publication of IL100906A publication Critical patent/IL100906A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/02—Hydroxy-anthraquinones; Ethers or esters thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
    • C09B67/0034—Mixtures of two or more pigments or dyes of the same type
    • C09B67/0038—Mixtures of anthraquinones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10090692A 1991-02-13 1992-02-10 Pharmaceutical compositions comprising carminic acid and optionally one or more quinones IL100906A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use

Publications (2)

Publication Number Publication Date
IL100906A0 IL100906A0 (en) 1992-11-15
IL100906A true IL100906A (en) 1996-09-12

Family

ID=10689992

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10090692A IL100906A (en) 1991-02-13 1992-02-10 Pharmaceutical compositions comprising carminic acid and optionally one or more quinones

Country Status (30)

Country Link
EP (1) EP0499467A3 (cs)
JP (1) JPH06505231A (cs)
CN (1) CN1064407A (cs)
AP (1) AP549A (cs)
AU (2) AU1233992A (cs)
BG (1) BG61025B1 (cs)
BR (1) BR9205642A (cs)
CA (1) CA2104009A1 (cs)
CZ (1) CZ166893A3 (cs)
DZ (1) DZ1559A1 (cs)
FI (1) FI933595A7 (cs)
GB (2) GB9103075D0 (cs)
GT (1) GT199200009A (cs)
HU (1) HUT65634A (cs)
IE (1) IE920464A1 (cs)
IL (1) IL100906A (cs)
IN (1) IN178929B (cs)
IS (1) IS3814A (cs)
JO (1) JO1719B1 (cs)
LT (1) LT3197B (cs)
MA (1) MA22443A1 (cs)
MX (1) MX9200622A (cs)
MY (1) MY131098A (cs)
NO (1) NO932681L (cs)
NZ (2) NZ240487A (cs)
OA (2) OA09535A (cs)
SK (1) SK87993A3 (cs)
TN (1) TNSN92015A1 (cs)
WO (1) WO1992014454A1 (cs)
ZA (1) ZA921037B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
CA2185817A1 (en) * 1994-03-17 1995-09-21 Washington Odur Ayuko Anti-viral and anti-cancer agents
DE59409088D1 (de) * 1994-10-04 2000-02-24 Lohmann Rudolf Lomapharm Lösungen von Anthrachinonen zur parenteralen Applikation
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
CA2696304A1 (en) 2007-08-08 2009-02-12 Bionovo, Inc. Estrogenic extracts of ligustrum lucidum ait. of the oleaceae family and uses thereof
EP2194999A4 (en) 2007-09-07 2012-03-21 Bionovo Inc ESTROGENIC EXTRACTS OF ASTRAGALUS MEMBRANACEUS FISCH.BGE.VAR.MONGOLICUS BGE. THE FAMILY LEGUMINOSAE AND ITS APPLICATIONS
JP2010538093A (ja) 2007-09-07 2010-12-09 バイオノボ・インコーポレーテッド シソ科ファミリーのセイタカナミキソウのエストロゲン性抽出物およびその使用
EP2194998A4 (en) 2007-09-07 2012-03-21 Bionovo Inc STROGENIC EXTRACTS OF ASPARAGUS CONCHINCHINENSIS (LOUR.) MERR OF THE LILIACEAE FAMILY AND USES THEREOF
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
WO2009067550A1 (en) 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
CA2706330A1 (en) 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
JP2011522822A (ja) * 2008-06-06 2011-08-04 バイオノボ・インコーポレーテッド エストロゲン受容体β媒介性病状の治療のためのダイオウ（Ｒｈｅｕｍｐａｌｍａｔｕｍ）由来のアントラキノンおよび類似体
US9884815B2 (en) 2011-10-14 2018-02-06 Emory University PGAM1 inhibitors and methods related thereto
CZ304335B6 (cs) * 2012-02-22 2014-03-12 Mikrobiologický ústav AV ČR, v. v. i. Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití
CA3105413A1 (en) * 2018-07-17 2020-01-23 Pili Anthraquinonic derivatives and their use as colouring agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7708452L (sv) * 1977-07-22 1979-01-23 Allied Chem Komposition innehallande en antrakinonforening
JPS6054286B2 (ja) * 1979-09-18 1985-11-29 江澤 林 免疫増強剤
JPS6043210A (ja) * 1983-08-18 1985-03-07 Tdk Corp 磁気ヘツド及びその製造方法
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DE3601065A1 (de) * 1986-01-16 1987-07-23 Behringwerke Ag Chinon-derivate als antitumormittel
WO1989005141A1 (fr) * 1987-12-10 1989-06-15 Tsumura Juntendo, Inc. Medicament antiretroviral
DE68928964T2 (de) * 1988-08-16 1999-07-29 The Wellcome Foundation Ltd., London Neue Naphthochinone und ihre Anwendung als Arzneimittel
EP0524212A1 (en) * 1990-04-03 1993-01-27 Radopath Limited Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen

Also Published As

Publication number Publication date
AU1233992A (en) 1992-09-15
HUT65634A (en) 1994-07-28
BR9205642A (pt) 1994-06-21
HU9302347D0 (en) 1993-10-28
EP0499467A3 (en) 1992-12-16
NO932681L (no) 1993-10-07
GT199200009A (es) 1993-08-06
NZ241593A (en) 1995-05-26
TNSN92015A1 (fr) 1993-06-08
FI933595A0 (fi) 1993-08-13
BG98041A (bg) 1994-05-27
AP9200356A0 (en) 1992-04-30
JPH06505231A (ja) 1994-06-16
MX9200622A (es) 1992-11-01
WO1992014454A1 (en) 1992-09-03
ZA921037B (en) 1992-11-25
IN178929B (cs) 1997-07-19
AP549A (en) 1996-11-01
JO1719B1 (en) 1992-12-15
IE920464A1 (en) 1992-08-12
CZ166893A3 (en) 1994-03-16
OA09535A (en) 1992-11-15
DZ1559A1 (fr) 2002-02-17
OA09810A (en) 1994-04-15
NO932681D0 (no) 1993-07-26
FI933595A7 (fi) 1993-08-13
MY131098A (en) 2007-07-31
IL100906A0 (en) 1992-11-15
GB9203084D0 (en) 1992-03-25
GB2254554A (en) 1992-10-14
LTIP329A (en) 1994-08-25
GB2254554B (en) 1995-09-20
NZ240487A (en) 1994-03-25
CN1064407A (zh) 1992-09-16
GB9103075D0 (en) 1991-03-27
BG61025B1 (bg) 1996-09-30
IS3814A (is) 1992-08-14
AU5590696A (en) 1996-08-08
SK87993A3 (en) 1993-12-08
EP0499467A2 (en) 1992-08-19
CA2104009A1 (en) 1992-08-14
LT3197B (en) 1995-03-27
MA22443A1 (fr) 1992-10-01

Similar Documents

Publication Publication Date Title
AP549A (en) Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections.
US6811788B2 (en) Combinations and methods for treating neoplasms
US8501243B2 (en) Targeting cancer therapy combination
Schultz Case study: high-dose intravenous vitamin C in the treatment of a patient with adenocarcinoma of the kidney
US4481195A (en) Method for the treatment of tumors with β-glucuronidase activity dependent pharmaceuticals
Saiki et al. Effect of schedule on activity and toxicity of 5‐azacytidine in acute leukemia: a southwest oncology group study
US6720011B1 (en) Injectable composition for cancer treatment
EP0281380A2 (en) Synergistic interplay of interleukin-2 and dsRNAs
AU662883B2 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
OA12862A (en) Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone.
Donelli et al. Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?
CN105380956B (zh) 一种治疗白血病的含艾德拉尼的药物组合物及应用
US7439234B2 (en) Method for treating cancer patients undergoing chemotherapy
KR100302994B1 (ko) 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용
RU2129867C1 (ru) Средство для профилактики и лечения инфекционных заболеваний и коррекции патологических состояний живого организма
JP2004315470A (ja) ヨウ化ナトリウム含有製剤
HRP920891A2 (en) Quinone preparation
CN117243963B (zh) Remodelin与Venetoclax在治疗癌症中的应用
Grandics Complete remission achieved in a case of both primary and recurrent adult acute myelogeneous leukemia by a novel nutritional therapy
ES2315429T3 (es) Procedimiento para afectar la progresion neurologica.
US20110256236A1 (en) Enhancement of the Anti-Leukemic Effect of Thalidomide
CN106039323B (zh) ZD55-MnSOD联合顺铂在抑制卵巢癌细胞增殖中的用途
EP2068894B1 (en) Use of cis-rhenium (iii) diadamantate compounds for potentiating the antitumoral activity of platinium complexes
WO1997025044A1 (en) Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy
Hines et al. Nitrogen mustard as adjunctive chemotherapy for breast carcinoma

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted
RH Patent void